Dosage Adjustments : Many patients experience increased nausea when doses are escalated during the treatment initiation phase
Completed clinical trials with unknown status, no recent updates, no public or published results, and no relevance to the subject of the current review were excluded
With proper support and management, the majority of patients successfully navigate the initial adjustment period and achieve sustained benefit from Mounjaro therapy whilst maintaining acceptable gastrointestinal function and quality of life
These differences can affect how patients respond to treatment, how dosing is managed, and what type of weight loss results are achievable over time
Supports cardiovascular function in the body's highest energy-demand tissue*
[PMID: 12078865] PubMed record related to this compound for laboratory literature review